Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

SHA:600664 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,802	3,634	3,060	2,433	1,592	897
Cash & Short-Term Investments	2,802	3,634	3,060	2,433	1,592	897
Cash Growth	-1.58%	18.75%	25.76%	52.85%	77.49%	32.79%
Accounts Receivable	5,424	4,985	4,961	4,818	4,749	4,703
Other Receivables	144.35	130.8	146.47	178.51	85.86	34.19
Receivables	5,568	5,116	5,107	4,997	4,835	4,737
Inventory	1,825	1,891	1,924	1,804	2,064	1,862
Prepaid Expenses	-	-	10.7	4.93	-	-
Other Current Assets	303.31	337.47	293.61	320.05	242.45	312
Total Current Assets	10,499	10,979	10,396	9,560	8,733	7,808
Property, Plant & Equipment	2,340	2,385	2,468	2,641	2,835	2,783
Long-Term Investments	33.49	33.49	38.42	37.62	39.32	48.72
Goodwill	39.16	39.16	39.15	39.15	39.15	-
Other Intangible Assets	400.46	408.4	451.14	444.21	480.78	494.1
Long-Term Deferred Tax Assets	602.94	603.74	597.85	600.19	599.44	602.86
Long-Term Deferred Charges	67.4	63.4	41.29	63.96	71.76	64.58
Other Long-Term Assets	111.53	104.24	80.16	48.84	44.11	46.14
Total Assets	14,094	14,616	14,112	13,435	12,842	11,848
Accounts Payable	3,954	4,039	3,951	3,510	3,482	3,668
Accrued Expenses	494.89	572.9	597.07	668.02	628.3	656.59
Short-Term Debt	1,149	1,554	1,658	1,933	2,078	1,634
Current Portion of Long-Term Debt	140.38	148.42	104.04	103.64	102.92	102.93
Current Portion of Leases	-	-	31.21	35.93	36.74	-
Current Income Taxes Payable	140.7	104.66	80.1	98.29	85.17	60.49
Current Unearned Revenue	80.35	304.7	282.45	235.87	119.73	98.33
Other Current Liabilities	1,412	1,381	1,539	1,417	1,322	1,087
Total Current Liabilities	7,372	8,105	8,243	8,002	7,855	7,307
Long-Term Debt	31.92	31.7	32.63	33.19	34.09	36.7
Long-Term Leases	33.55	35.32	31.08	43.68	61.61	-
Long-Term Unearned Revenue	294.84	300.74	319.07	333.61	375.1	407.82
Long-Term Deferred Tax Liabilities	5.72	5.73	6.91	6.29	1.68	1.61
Other Long-Term Liabilities	47.98	47.98	56.64	69.7	94.7	106.05
Total Liabilities	7,786	8,526	8,689	8,488	8,422	7,859
Common Stock	2,519	2,519	2,521	2,526	2,518	2,507
Additional Paid-In Capital	684.11	684.11	685.32	688.6	675.43	662.57
Retained Earnings	4,124	3,911	3,282	2,887	2,426	2,054
Treasury Stock	-	-	-3.98	-13.01	-15.53	-
Comprehensive Income & Other	-1,763	-1,763	-1,760	-1,760	-1,757	-1,744
Total Common Equity	5,563	5,350	4,724	4,328	3,847	3,480
Minority Interest	745.28	739.49	698.75	618.87	573.25	508.92
Shareholders' Equity	6,308	6,089	5,423	4,947	4,420	3,989
Total Liabilities & Equity	14,094	14,616	14,112	13,435	12,842	11,848
Total Debt	1,355	1,770	1,857	2,149	2,313	1,774
Net Cash (Debt)	1,447	1,864	1,203	284.1	-720.94	-876.71
Net Cash Growth	70.92%	54.94%	323.57%	-	-	-
Net Cash Per Share	0.57	0.74	0.49	0.11	-0.29	-0.35
Filing Date Shares Outstanding	2,662	2,437	2,521	2,526	2,518	2,507
Total Common Shares Outstanding	2,662	2,437	2,521	2,526	2,518	2,507
Working Capital	3,127	2,874	2,153	1,558	878.23	501.08
Book Value Per Share	2.09	2.20	1.87	1.71	1.53	1.39
Tangible Book Value	5,123	4,902	4,234	3,844	3,327	2,986
Tangible Book Value Per Share	1.92	2.01	1.68	1.52	1.32	1.19
Buildings	-	-	4,644	4,702	4,683	4,605
Machinery	-	-	3,214	3,169	3,545	3,743
Construction In Progress	-	-	69.12	66.22	164.92	159.79

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.